Lobbying client
CENTIVAX
Biotechnology Company
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
—
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2021
Filings
7 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2021
|
THE CONAFAY GROUP, LLC | — reported |
|
2nd Quarter - Report 2nd Quarter 2021
|
THE CONAFAY GROUP, LLC | — reported |
|
1st Quarter - Report 1st Quarter 2021
|
THE CONAFAY GROUP, LLC | — reported |
|
4th Quarter - Report 4th Quarter 2020
|
THE CONAFAY GROUP, LLC | — reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
THE CONAFAY GROUP, LLC | — reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
THE CONAFAY GROUP, LLC | — reported |
|
Registration 2nd Quarter 2020
|
THE CONAFAY GROUP, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE CONAFAY GROUP, LLC | 6 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 6 |
| Budget/Appropriations | BUD | 5 |
| Health Issues | HCR | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.